Gufic Biosciences Limited Vancomycin Export Data — India (DGFT 2022–2026)

Name: Gufic Biosciences Limited Vancomycin Export Records India — #7 Exporter, 165 Shipments, $5.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vancomycin

India Pharmaceutical Trade Intelligence

$92.2M318 Suppliers140 CountriesHS 30042096

ExportsIndia → UNITED STATES54.8%India → GERMANY8.8%

ImportsCHINA → India$301.9K UNITED STATES → India$74.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN INSTITUTIONAL

Gufic Biosciences Limited — Vancomycin Exporter #7 | $5.2M Trade Value | TransData Nexus | TransData Nexus

Gufic Biosciences Limited — Vancomycin Exporter Profile

Indian Pharmaceutical Exporter · #7 for Vancomycin · $5.2M export value · DGFT Verified

Gufic Biosciences Limited is the #7 Indian exporter of Vancomycin with $5.2M in export value and 165 verified shipments. Gufic Biosciences Limited holds a 5.6% market share in Vancomycin exports across 12 countries. The company exports 5 pharmaceutical products worth $12.6M across 4 therapeutic categories.

Gufic Biosciences Limited — Vancomycin Export Profile: Buyers & Destinations

Gufic Biosciences Limited Vancomycin export treemap — buyers and destination countries | TransData Nexus

Where Does Gufic Biosciences Limited Export Vancomycin?

Country	Value	Shipments	Share
GERMANY	$2.1M	47	59.7%
HUNGARY	$375.3K	43	10.7%
SRI LANKA	$295.5K	27	8.4%
MALAYSIA	$260.4K	6	7.4%
COLOMBIA	$147.0K	7

Who Are the Top Buyers of Vancomycin from Gufic Biosciences Limited?

Buyer	Country	Value	Orders
HANSE SERVICE INTERNATIONALE	GERMANY	$1.6M	34
TO THE ORDER OF	MALAYSIA	$587.1K	62
HANSE SERVICE	GERMANY	$329.5K	8
SLIM PHARMACEUTICALS (PVT) LTD,	SRI LANKA	$188.2K	16
HANSE SERVICE INTERNATIONALE,	GERMANY	$187.6K	5
TO THE ORDER OF BANK ISLAM MALAYSIA	MALAYSIA	$150.0K	3
LIFELINE CO LTD	MYANMAR	$61.3K	2
SGS PHARMA MAG. KFT,	HUNGARY	$57.0K	2
EVENSEN CONTINENTAL CORPORATION AN	COLOMBIA	$50.0K	1
EVENSEN CONTINENTAL CORPORATION AND	COLOMBIA	$44.8K	3

Gufic Biosciences Limited supplies Vancomycin to 25 buyers globally. The largest buyer is HANSE SERVICE INTERNATIONALE (GERMANY), followed by TO THE ORDER OF (MALAYSIA) and HANSE SERVICE (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vancomycin Formulations Does Gufic Biosciences Limited Export?

Product Description / Formulation	Value	Shipments
VANCOMYCIN DR. EBERTH 500MG (VANCOMYCIN	$555.9K	12
VANCOMYCIN DR. EBERTH 1000MG (VANCOMYCIN	$550.0K	11
VANCOMYCIN HYDROCHLORIDE POWDER 500 MG (	$100.0K	2
VAMOCIN 500 INJ (VANCOMYCIN HYDROCHLORID	$70.4K	2
VAMOCIN (VANCOMYCIN HYDROCHLORIDE INJECT	$68.1K	3
VAMOCIN 500 INJ (VANCOMYCIN HYDROCHLORI	$50.0K	1
VANCOMYCIN 500 MG INJ - VANCOMYCIN HYD	$50.0K	1
VANCOMYCIN DR. EBERTH 500MG VANCOMYCINHCL POWDER OF INJ 500 MG PACK SIZE-1X10?S, 8,250 PACKS, 82,500 VIALS	$50.0K	1
VANCOMYCIN DR. EBERTH 1000MG VANCOMYCINHCL POWDER OF INJ 1000 MG PACK SIZE-1X10?S 7783 PACKS, 77830 VIALS	$50.0K	1
VANCOMYCIN DR. EBERTH 1000MG VANCOMYCINHCL POWDER OF INJ 1000 MG PACK SIZE-1X10?S 9981 PACKS 99810 VIALS	$50.0K	1

Gufic Biosciences Limited exports 112 distinct Vancomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VANCOMYCIN DR. EBERTH 500MG (VANCOMYCIN with 12 shipments worth $555.9K.

How Does Gufic Biosciences Limited Compare to Nearest Vancomycin Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	GLAND PHARMA LIMITED	$5.4M	108	7	$50.0K
6	ASPIRO PHARMA LIMITED	$5.4M	149	19	$36.1K
7	GUFIC BIOSCIENCES LIMITED ★	$5.2M	165	12	$31.3K
5	GLAND PHARMA LTD	$3.0M	59	7	$50.0K
8	LUPIN LIMITED	$2.5M	49	1	$50.0K

Gufic Biosciences Limited ranks #7 among 318 Indian Vancomycin exporters. Average shipment value of $31.3K compared to the market average of $184.6K. The closest competitors by value are GLAND PHARMA LIMITED and ASPIRO PHARMA LIMITED.

Which Indian Ports Ship Vancomycin Exports?

Port	Shipments	% Share
SAHAR AIR	406	13.2%
SAHAR AIR CARGO ACC (INBOM4)	395	12.9%
NHAVA SHEVA SEA (INNSA1)	221	7.2%
DELHI AIR	135	4.4%
BANGALORE ACC (INBLR4)	134	4.4%
BANGALORE AIR	133	4.3%
BANGALORE ICD (INWFD6)	119	3.9%
HYDERABAD ACC (INHYD4)	116	3.8%

Geopolitical & Trade Policy Impact on Gufic Biosciences Limited's Vancomycin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Gufic Biosciences. The Israel-Iran conflict has led to increased tensions in the Red Sea, a vital shipping route for Indian exports. Houthi attacks in the region have disrupted maritime logistics, resulting in higher shipping costs and potential delays. These disruptions could impact Gufic's supply chain efficiency and delivery timelines, necessitating strategic adjustments to maintain export commitments.

In the United States, recent tariff policies have introduced uncertainties for pharmaceutical imports. While health products have been exempt from tariffs, there have been threats to impose significant increases to encourage domestic production. Such measures could affect Indian exporters, including Gufic, by altering the competitive landscape and potentially reducing market share in the U.S. (lemonde.fr)

Conversely, U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to fill gaps left by Chinese suppliers. Gufic could leverage this opportunity to expand its footprint in markets seeking alternative sources for pharmaceutical products.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The directive mandates stringent serialization and traceability measures to prevent counterfeit medicines from entering the supply chain. Gufic's adherence to these regulations is essential to maintain and grow its presence in the EU market.

Gufic Biosciences Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gufic's Indore facility, which commenced production in October 2024, is designed to meet WHO GMP, EU GMP, ANVISA, MHRA, and USFDA standards. This facility has achieved 30% capacity utilization for FY26 and is on track for EBITDA breakeven. Such compliance not only facilitates market access but also enhances the company's reputation for quality and reliability. (scanx.trade)

However, recent tax-related penalties highlight the importance of robust internal controls and adherence to financial regulations. Gufic's proactive approach in appealing these penalties demonstrates its commitment to regulatory compliance and financial integrity.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Gufic Biosciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 165 individual customs records matching Gufic Biosciences Limited exporting Vancomycin, covering 112 formulations to 12 countries via 25 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 140+ countries, 743+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vancomycin

Vancomycin

Gufic Biosciences Limited — Vancomycin Exporter Profile

Gufic Biosciences Limited — Vancomycin Export Profile: Buyers & Destinations

Where Does Gufic Biosciences Limited Export Vancomycin?

Who Are the Top Buyers of Vancomycin from Gufic Biosciences Limited?

What Is India's Total Vancomycin Export Value and How Much Does Gufic Biosciences Limited Contribute?

What Is the Average Shipment Value for Gufic Biosciences Limited's Vancomycin Exports?

How Does Gufic Biosciences Limited Compare to Other Indian Vancomycin Exporters?

What Vancomycin Formulations Does Gufic Biosciences Limited Export?

Regulatory Requirements: Exporting Vancomycin to Key Markets

Germany — BfArM/EMA

How Does Gufic Biosciences Limited Compare to Nearest Vancomycin Exporters?

Which Indian Ports Ship Vancomycin Exports?

Geopolitical & Trade Policy Impact on Gufic Biosciences Limited's Vancomycin Exports

Gufic Biosciences Limited — Regulatory Compliance & Quality Standards

About Gufic Biosciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vancomycin Export Data from Gufic Biosciences Limited

Vancomycin Stats

Company Overview

Top Products by Gufic Biosciences Limited

Related Analysis

Need Detailed Export Data?

Data Source